Clinical trial Recruiting at 1 site Observational Ages 18 and up

dPmax test to predict RV failure after LVAD implantation

Official title: Predictive Value of dPmax Measured by Pulse Contour Analysis for Postoperative Right Ventricular Failure in Patients Undergoing LVAD Implantation

Run by Etlik Zubeyde Hanım Women's Health Care, Training and Research Hospital · NCT07918690 · Data updated 2026-11-12

A single-center study will see if dPmax, measured from arterial pressure data, can help predict right ventricular failure after LVAD surgery in adults.

More Right Ventricular Dysfunction trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment89 (estimated)
SponsorEtlik Zubeyde Hanım Women's Health Care, Training and Research Hospital
Academic / other
Locations1 site (Ankara, Çankaya)
StatusRecruiting
StartedJune 3, 2026
Main results expectedSeptember 2029
Study endsNovember 2029
Registry record updatedNovember 5, 2026
Trial IDNCT07918690 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) scheduled for LVAD implantation with available required clinical data and able to consent.

Probably not a fit

Patients in whom arterial waveform analysis cannot be reliably performed or who do not develop RV failure may not derive predictive benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective observational study analyzes arterial pressure waveform data collected during routine care before and after anesthesia in adults scheduled for LVAD placement. Researchers will compare dPmax measurements with preoperative echo findings and the TAPSE/SPAP ratio to predict right ventricular failure within 30 days after surgery using MCS-ARC criteria. No extra invasive procedures are added for research beyond standard monitoring. The goal is to identify a dPmax threshold that best predicts RV failure and to gauge its predictive performance relative to existing measures.

Why it matters

Potential benefit: If successful, dPmax could improve early prediction of RV failure after LVAD, guiding perioperative planning and management.

How similar studies have gone: Similar hemodynamic waveform analyses have shown promise in predicting cardiac complications, but this specific dPmax approach for LVAD-related RV failure is exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 years or older.
* Scheduled for left ventricular assist device (LVAD) implantation.
* Availability of the clinical data required for the study.
* Willingness and ability to provide informed consent.

Exclusion Criteria:

* Congenital heart disease associated with transposition of the great arteries.
* Ongoing extracorporeal membrane oxygenation (ECMO) or extracorporeal ventricular assist device (ExVAD) support immediately before LVAD implantation.
* Severe aortic regurgitation, severe peripheral arterial disease, or refractory and uncontrolled tachyarrhythmia that may interfere with arterial waveform analysis.
* Unwillingness to participate or cognitive impairment preventing informed consent.

Where it's running

  • Ankara Bilkent City Hospital
    Ankara, Çankaya, Turkey (Türkiye)
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.